Catalysts for Lannett Co Inc
120 tracked
Apr 15, 2026
drug shortage
Methylphenidate Hydrochloride Tablet, Extended Release shortage โ Lannett Company, Inc.
Lannett Co Inc
โ
Apr 15, 2026
drug shortage
Lisdexamfetamine Dimesylate Capsule shortage โ Lannett Company, Inc.
Lannett Co Inc
โ
Apr 15, 2026
drug shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage โ Lannett Company, Inc.
Lannett Co Inc
โ
Mar 31, 2026
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 23, 2025
approval
ORLYNVAH (PROBENECID) โ FDA approval
Lannett Co Inc
โ
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 8, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 8, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Oct 29, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
โ
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
METADATE ER
โ
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
METADATE ER
โ
Sep 18, 2025
grant
BROWN UNIVERSITY โ Probenecid for Alcohol Use Disorder
Lannett Co Inc
โ
Sep 17, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
โ
Sep 3, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
โ
Mar 24, 2025
approval
ORLYNVAH (PROBENECID) โ FDA approval
Lannett Co Inc
โ
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 11, 2024
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
โ
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Oct 25, 2024
approval
ORLYNVAH (PROBENECID) โ FDA approval
Lannett Co Inc
โ
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Mar 13, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 15, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) โ FDA approval
acetaminophen ER
โ